Molina Healthcare, Inc. (NYSE:MOH) Director John C. Molina sold 6,400 shares of the stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $78.18, for a total transaction of $500,352.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
John C. Molina also recently made the following trade(s):
- On Thursday, January 18th, John C. Molina sold 16,226 shares of Molina Healthcare stock. The shares were sold at an average price of $92.49, for a total transaction of $1,500,742.74.
- On Monday, December 18th, John C. Molina sold 19,885 shares of Molina Healthcare stock. The shares were sold at an average price of $75.47, for a total transaction of $1,500,720.95.
Shares of Molina Healthcare, Inc. (NYSE:MOH) traded down $2.21 during trading hours on Wednesday, reaching $73.25. 1,424,872 shares of the company’s stock were exchanged, compared to its average volume of 1,464,112. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.29 and a quick ratio of 1.29. Molina Healthcare, Inc. has a 12-month low of $42.56 and a 12-month high of $93.98. The company has a market capitalization of $4,250.00, a price-to-earnings ratio of -9.07, a PEG ratio of 0.91 and a beta of 1.10.
Several equities analysts recently weighed in on MOH shares. Wolfe Research upgraded shares of Molina Healthcare from a “market perform” rating to an “outperform” rating in a research report on Monday, October 23rd. Zacks Investment Research upgraded shares of Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $88.00 target price for the company in a research report on Tuesday, January 2nd. Morgan Stanley increased their target price on shares of Molina Healthcare from $68.00 to $89.00 and gave the stock an “overweight” rating in a research report on Friday, November 3rd. Goldman Sachs Group started coverage on shares of Molina Healthcare in a research report on Wednesday, January 3rd. They set a “neutral” rating and a $83.00 target price for the company. Finally, JPMorgan Chase & Co. upgraded shares of Molina Healthcare from a “neutral” rating to an “overweight” rating in a research report on Tuesday, January 16th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the company’s stock. Molina Healthcare currently has an average rating of “Hold” and an average price target of $72.50.
Molina Healthcare Company Profile
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.